Element Biosciences AVITI¿ 24 sequencing and spati

The Department of the Interior's Interior Business Center is procuring one Element Biosciences AVITI24 Sequencing and Spatial Biology System with one Individually Addressable Lanes Enablement on behalf of the National Cancer Institute's Center for Cancer Research, with capability statements due August 27. This is a sole-source, firm-fixed-price acquisition negotiated directly with Element Biosciences under FAR 12.201-1 (Revolutionary FAR Overhaul).

Place of performance is the National Cancer Institute Main Campus in Bethesda, Maryland. Delivery and installation must occur within four to twelve weeks after contract award. The system must integrate next-generation sequencing, high-resolution imaging, spatial cytoprofiling, and direct in situ sequencing on a single instrument, support flexible sequencing configurations across multiple flow cell formats, accept standard sequencing libraries without conversion, deliver subcellular-resolution imaging for cell segmentation and spatial analysis, and support highly multiplexed applications including RNA profiling, protein detection, mutation analysis, immune receptor profiling, and optical pooled screening. The contractor shall provide manufacturer-authorized training within one week of installation by Element Biosciences application specialists or field service engineers, with additional technical support as needed. All hardware, optics, computing components, software licenses, accessories, manufacturer warranty coverage, and user training for core facility personnel are included. Payment is due after delivery, installation, and Government acceptance. The NAICS code is 334516, Analytical Laboratory Instrument Manufacturing; the PSC is 6650, Optical Instruments, Test Equipment, Components And Accessories. Jose Gomez is the Contracting Officer; capability statements should be sent to jose_gomez@ibc.doi.gov and may not exceed five pages in Microsoft Office or Adobe Acrobat format.